BioMérieux Recalls VITEK 2 Gram Negative Susceptibility Cards Due to Temperature Excursion
BioMérieux is recalling VITEK 2 Gram Negative Susceptibility Cards shipped to Guadeloupe that experienced a temperature excursion exceeding acceptable limits.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or adverse health consequences. The hazard is a potential loss of product efficacy due to temperature exposure, which fits the criteria for a moderate risk or precautionary recall.
Plain-English summary
BioMérieux SA is recalling 135 units (78 boxes) of VITEK 2 Gram Negative Susceptibility Cards (Ref: 413117, Lot Number 6330343103). The product is an in vitro test used in clinical laboratories to determine the susceptibility of aerobic gram-negative bacilli to antimicrobial agents.
The recall was initiated because a shipment to Guadeloupe suffered a temperature excursion up to 47.8°C, which exceeded the acceptable limits for the product. After the issue was detected, BioMérieux's Global Supply Chain QA team asked the local distributor to place the products in quarantine in July 2017. However, the distributor informed BioMérieux in November 2017 that the products had already been delivered to customers.
The affected products were distributed internationally, specifically to customers in Guadeloupe. Clinical laboratories and healthcare facilities that received these specific lots should stop using the cards and contact BioMérieux for further instructions or replacement.
The recalled product
- Product
- The VITEK 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of clinically significant aerobic gram negative bacilli to antimicrobial agents. Fully automated short-term
- Manufacturer
- BioMerieux SA
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- VITEK¿ 2 AST-N233 (ref: 413117): Lot Number 6330343103
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 9 recalled by BioMerieux SA under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 9 products in this recall →Related recalls
Same manufacturer · BioMerieux SA
See all →- HighMYLA Diagnostic System Software Versions Recalled for Risk of False Negatives
FDA (Devices) · 2021-10-20
- HighMYLA Laboratory Software: Potential Test Result Alteration from Software Anomaly
FDA (Devices) · 2021-08-18
- ModerateBioMerieux NucliSENS Magnetic Extraction Reagents Recalled Due to Temperature Exposure
FDA (Devices) · 2018-10-31
- ModerateBioMerieux Recalls VIDAS FSH Assay Kits Due to Calibration Issues
FDA (Devices) · 2018-07-04
- ModerateBioMérieux PREVI Color Gram Reagents Recalled Due to Temperature Excursion
FDA (Devices) · 2018-06-20
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30